.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Eposter presentation
PP31.14

The relationship between activity administered and time of acquisition per bed position for ⁶⁸Ga radiopharmaceuticals.

Termin

Datum: 13.09.2024

Zeit: 15:03 – 15:07

Redezeit: 3 Min.

Diskussionszeit: 1 Min.

Ort / Stream:

Poster Terminal 2 (ground floor)

Poster

The relationship between activity administered and time of acquisition per bed position for ⁶⁸Ga radiopharmaceuticals.

Session

Diagnostic and therapeutic nuclear medicine II

Themen

Diagnostic and therapeutic nuclear medicine
Innovative radiotherapy and medical imaging

Mitwirkende

Sam Agius (Msida / MT), Kirsty Mangion (Msida / MT)

The relationship between activity administered and time of acquisition per bed position for 68Ga radiopharmaceuticals.

Termin

Poster

Session

Themen

Mitwirkende

The relationship between activity administered and time of acquisition per bed position for ⁶⁸Ga radiopharmaceuticals.